Production of H5N1 influenza virus matrix protein 2 ectodomain protein bodies in tobacco plants and in insect cells as a candidate universal influenza vaccine

Frontiers in Bioengineering and Biotechnology

Volumn 3, Issue , 2015, Pages

  Mbewana, Sandiswa ^a   Mortimer, Elizabeth ^a   Pêra, Francisco F P G ^a   Hitzeroth, Inga Isabel ^a   Rybicki, Edward P ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Influenza Aa virus; Insect cell expression; M2e; Plant expression; Vaccine

Indexed keywords

CYTOLOGY; ELECTROPHORESIS; GENE ENCODING; MAMMALS; PLANTS (BOTANY); VACCINES; VIRUSES;

EXPRESSION SYSTEM; HIGHLY PATHOGENIC AVIAN INFLUENZAS; INFLUENZA VACCINES; INSECT CELLS; NICOTIANA BENTHAMIANA; PLANT EXPRESSIONS; PROLINE-RICH DOMAINS; WESTERN-BLOT ANALYSIS;

PROTEINS;

EID: 85003277862     PISSN: None     EISSN: 22964185     Source Type: Journal    
DOI: 10.3389/fbioe.2015.00197     Document Type: Article

References (53)

1. Andersson, A. M., Hakansson, K. O., Jensen, B. A., Christensen, D., Andersen, P., Thomsen, A. R., et al. (2012). Increased immunogenicity and protective efficacy of influenza M2e fused to a tetramerizing protein. PLoS One 7:e46395. doi:10.1371/journal.pone.0046395
2. Betakova, T. (2007). M2 protein-a proton channel of influenza A virus. Curr. Pharm. Des. 13, 3231-3235. doi:10.2174/138161207782341295
3. Black, R. A., Rota, P. A., Gorodkova, N., Cramer, A., Klenk, H. D., and Kendal, A. P. (1993). Production of the M2 protein of influenza A virus in insect cells is enhanced in the presence of amantadine. J. Gen. Virol. 74(Pt 8), 1673-1677. doi:10.1099/0022-1317-74-1-143
4. Chen, B. J., Leser, G. P., Jackson, D., and Lamb, R. A. (2008). The influenza virus M2 protein cytoplasmic tail interacts with the M1 protein and influences virus assembly at the site of virus budding. J. Virol. 82, 10059-10070. doi:10.1128/JVI.01184-08
5. Cox, M. M. (2008). Progress on baculovirus-derived influenza vaccines. Curr. Opin. Mol. Ther. 10, 56-61
6. Cox, N. J., and Subbarao, K. (1999). Influenza. Lancet 354, 1277-1282. doi:10.1016/S0140-6736(99)01241-6
7. D'Aoust, M. A., Lavoie, P. O., Couture, M. M., Trepanier, S., Guay, J. M., Dargis, M., et al. (2008). Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice. Plant Biotechnol. J. 6, 930-940. doi:10.1111/j.1467-7652.2008.00384.x
8. De Filette, M., Martens, W., Smet, A., Schotsaert, M., Birkett, A., Londono-Arcila, P., et al. (2008). Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies. Vaccine 26, 6503-6507. doi:10.1016/j.vaccine.2008.09.038
9. De Filette, M., Min Jou, W., Birkett, A., Lyons, K., Schultz, B., Tonkyro, A., et al. (2005). Universal influenza A vaccine: optimization of M2-based constructs. Virology 337, 149-161. doi:10.1016/j.virol.2005.04.004
10. Denis, J., Acosta-Ramirez, E., Zhao, Y., Hamelin, M. E., Koukavica, I., Baz, M., et al. (2008). Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform. Vaccine 26, 3395-3403. doi:10.1016/j.vaccine.2008.04.052
11. Feng, J., Zhang, M., Mozdzanowska, K., Zharikova, D., Hoff, H., Wunner, W., et al. (2006). Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2. Virol. J. 3, 102. doi:10.1186/1743-422X-3-102
12. Fiers, W., De Filette, M., Birkett, A., Neirynck, S., and Min Jou, W. (2004). A "universal" human influenza A vaccine. Virus Res. 103, 173-176. doi:10.1016/j. virusres.2004.02.030
13. Fiore, A. E., Bridges, C. B., and Cox, N. J. (2009). Seasonal influenza vaccines. Curr. Top. Microbiol. Immunol. 333, 43-82. doi:10.1007/978-3-540-92165-3_3
14. Firsov, A., Tarasenko, I., Mitiouchkina, T., Ismailova, N., Shaloiko, L., Vainstein, A., et al. (2015). High-yield expression of M2e peptide of avian influenza virus H5N1 in transgenic duckweed plants. Mol. Biotechnol. 57, 653-661. doi:10.1007/s12033-015-9855-4
15. Gomez, E., Zoth, S. C., and Berinstein, A. (2009). Plant-based vaccines for potential human application: a review. Hum. Vaccin. 5, 738-744. doi:10.4161/hv.5.11.9879
16. Gouy, M., and Gautier, C. (1982). Codon usage in bacteria: correlation with gene expressivity. Nucleic Acids Res. 10, 7055-7074. doi:10.1093/nar/10.22.7055
17. Holsinger, L. J., and Lamb, R. A. (1991). Influenza virus M2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds. Virology 183, 32-43. doi:10.1016/0042-6822(91)90115-R
18. Huleatt, J. W., Jacobs, A. R., Tang, J., Desai, P., Kopp, E. B., Huang, Y., et al. (2007). Vaccination with recombinant fusion proteins incorporating toll-like receptor ligands induces rapid cellular and humoral immunity. Vaccine 25, 763-775. doi:10.1016/j.vaccine.2006.08.013
19. Imai, M., Herfst, S., Sorrell, E. M., Schrauwen, E. J. A., Linster, M., De Graaf, M., et al. (2013). Transmission of influenza A/H5N1 viruses in mammals. Virus Res. 178, 15-20. doi:10.1016/j.virusres.2013.07.017
20. Ionescu, R. M., Przysiecki, C. T., Liang, X., Garsky, V. M., Fan, J., Wang, B., et al. (2006). Pharmaceutical and immunological evaluation of human papillomavirus virus-like particle as an antigen carrier. J. Pharm. Sci. 95, 70-79. doi:10.1002/jps.20493
21. Jegerlehner, A., Schmitz, N., Storni, T., and Bachmann, M. F. (2004). Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity. J. Immunol. 172, 5598-5605. doi:10.4049/jimmunol.172.9.5598
22. Johansson, B. E., Bucher, D. J., Pokorny, B. A., Mikhail, A., and Kilbourne, E. D. (1989). Identification of PR8 M1 protein in influenza virus high-yield reassortants by M1-specific monoclonal antibodies. Virology 171, 634-636. doi:10.1016/0042-6822(89)90638-7
23. Joseph, M., Ludevid, M. D., Torrent, M., Rofidal, V., Tauzin, M., Rossignol, M., et al. (2012). Proteomic characterisation of endoplasmic reticulum-derived protein bodies in tobacco leaves. BMC Plant Biol. 12:36. doi:10.1186/1471-2229-12-36
24. Kaplan, B. S., and Webby, R. J. (2013). The avian and mammalian host range of highly pathogenic avian H5N1 influenza. Virus Res. 178, 3-11. doi:10.1016/j. virusres.2013.09.004
25. Lamb, R. A., Zebedee, S. L., and Richardson, C. D. (1985). Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface. Cell 40, 627-633. doi:10.1016/0092-8674(85)90211-9
26. Larkin, M. A., Blackshields, G., Brown, N. P., Chenna, R., McGettigan, P. A., McWilliam, H., et al. (2007). Clustal W and Clustal X version 2.0. Bioinformatics 23, 2947-2948. doi:10.1093/bioinformatics/btm404
27. Maclean, J., Koekemoer, M., Olivier, A. J., Stewart, D., Hitzeroth, I. I., Rademacher, T., et al. (2007). Optimization of human papillomavirus type 16 (HPV-16) L1 expression in plants: comparison of the suitability of different HPV-16 L1 gene variants and different cell-compartment localization. J. Gen. Virol. 88, 1460-1469. doi:10.1099/vir.0.82718-0
28. Mainieri, D., Rossi, M., Archinti, M., Bellucci, M., De Marchis, F., Vavassori, S., et al. (2004). Zeolin. A new recombinant storage protein constructed using maize gamma-zein and bean phaseolin. Plant Physiol 136, 3447-3456. doi:10.1104/pp.104.046409
29. Mardanova, E. S., Kotlyarov, R. Y., Kuprianov, V. V., Stepanova, L. A., Tsybalova, L. M., Lomonosoff, G. P., et al. (2015). Rapid high-yield expression of a candidate influenza vaccine based on the ectodomain of M2 protein linked to flagellin in plants using viral vectors. BMC Biotechnol. 15:42. doi:10.1186/s12896-015-0164-6
30. Matic, S., Rinaldi, R., Masenga, V., and Noris, E. (2011). Efficient production of chimeric human papillomavirus 16 L1 protein bearing the M2e influenza epitope in Nicotiana benthamiana plants. BMC Biotechnol. 11:106. doi:10.1186/1472-6750-11-106
31. Mortimer, E., Hitzertoth, I., Buys, A., Mbewana, S., and Rybicki, E. (2013). An H5N1 influenza DNA vaccine for South Africa. S. Afr. J. Sci. 109, 4. doi:10.1590/sajs.2013/20120053
32. Mortimer, E., Maclean, J. M., Mbewana, S., Buys, A., Williamson, A. L., Hitzeroth, I. I., et al. (2012). Setting up a platform for plant-based influenza virus vaccine production in South Africa. BMC Biotechnol. 12:14. doi:10.1186/1472-6750-12-14
33. Mozdzanowska, K., Feng, J., Eid, M., Kragol, G., Cudic, M., Otvos, L. Jr., et al. (2003). Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2. Vaccine 21, 2616-2626. doi:10.1016/S0264-410X(03)00040-9
34. Nemchinov, L. G., and Natilla, A. (2007). Transient expression of the ectodomain of matrix protein 2 (M2e) of avian influenza A virus in plants. Protein Expr. Purif. 56, 153-159. doi:10.1016/j.pep.2007.05.015
35. Park, E. K., Castrucci, M. R., Portner, A., and Kawaoka, Y. (1998). The M2 ectodomain is important for its incorporation into influenza A virions. J. Virol. 72, 2449-2455
36. Petukhova, N. V., Gasanova, T. V., Stepanova, L. A., Rusova, O. A., Potapchuk, M. V., Korotkov, A. V., et al. (2013). Immunogenicity and protective efficacy of candidate universal influenza A nanovaccines produced in plants by tobacco mosaic virus-based vectors. Curr. Pharm. Des. 19, 5587-5600. doi:10.2174/13 816128113199990337
37. Pinto, L. H., and Lamb, R. A. (2006). Influenza virus proton channels. Photochem. Photobiol. Sci. 5, 629-632. doi:10.1039/b517734k
38. Price, G. E., Soboleski, M. R., Lo, C.-Y., Misplon, J. A., Quirion, M. R., Houser, K. V., et al. (2010). Single-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 viruses. PLoS One 5:e13162. doi:10.1371/journal.pone.0013162
39. Ravin, N. V., Kotlyarov, R. Y., Mardanova, E. S., Kuprianov, V. V., Migunov, A. I., Stepanova, L. A., et al. (2012). Plant-produced recombinant influenza vaccine based on virus-like HBc particles carrying an extracellular domain of M2 protein. Biochemistry (Mosc) 77, 33-40. doi:10.1134/S000629791201004X
40. Rossman, J. S., Jing, X., Leser, G. P., Balannik, V., Pinto, L. H., and Lamb, R. A. (2010). Influenza virus m2 ion channel protein is necessary for filamentous virion formation. J. Virol. 84, 5078-5088. doi:10.1128/JVI.00119-10
41. Rybicki, E. P. (2009). Plant-produced vaccines: promise and reality. Drug Discov. Today 14, 16-24. doi:10.1016/j.drudis.2008.10.002
42. Safdar, A., and Cox, M. M. (2007). Baculovirus-expressed influenza vaccine. A novel technology for safe and expeditious vaccine production for human use. Expert Opin. Investig. Drugs 16, 927-934. doi:10.1517/13543784.16.7.927
43. Shoji, Y., Chichester, J. A., Bi, H., Musiychuk, K., de la Rosa, P., Goldschmidt, L., et al. (2008). Plant-expressed HA as a seasonal influenza vaccine candidate. Vaccine 26, 2930-2934. doi:10.1016/j.vaccine.2008.03.045
44. Stanekova, Z., Kiraly, J., Stropkovska, A., Mikuskova, T., Mucha, V., Kostolansky, F., et al. (2011). Heterosubtypic protective immunity against influenza A virus induced by fusion peptide of the hemagglutinin in comparison to ectodomain of M2 protein. Acta Virol. 55, 61-67. doi:10.4149/av_2011_01_61
45. Sugrue, R. J., and Hay, A. J. (1991). Structural characteristics of the M2 protein of influenza A viruses: evidence that it forms a tetrameric channel. Virology 180, 617-624. doi:10.1016/0042-6822(91)90075-M
46. Takeda, A., Sugiyama, K., Nagano, H., Mori, M., Kaido, M., Mise, K., et al. (2002). Identification of a novel RNA silencing suppressor, NSs protein of tomato spotted wilt virus. FEBS Lett 532, 75-79. doi:10.1016/S0014-5793(02)03632-3
47. Thompson, W. W., Shay, D. K., Weintraub, E., Brammer, L., Cox, N., Anderson, L. J., et al. (2003). Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289, 179-186. doi:10.1001/jama.289.2.179
48. Tompkins, S. M., Zhao, Z. S., Lo, C. Y., Misplon, J. A., Liu, T., Ye, Z., et al. (2007). Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1. Emerging Infect. Dis. 13, 426-435. doi:10.3201/eid1303.061125
49. Torrent, M., Llompart, B., Lasserre-Ramassamy, S., Llop-Tous, I., Bastida, M., Marzabal, P., et al. (2009). Eukaryotic protein production in designed storage organelles. BMC Biol. 7:5. doi:10.1186/1741-7007-7-5
50. Wang, L., Hess, A., Chang, T. Z., Wang, Y. C., Champion, J. A., Compans, R. W., et al. (2014). Nanoclusters self-assembled from conformation-stabilized influenza M2e as broadly cross-protective influenza vaccines. Nanomedicine 10, 473-482. doi:10.1016/j.nano.2013.08.005
51. Webster, R. G., Bean, W. J., Gorman, O. T., Chambers, T. M., and Kawaoka, Y. (1992). Evolution and ecology of influenza A viruses. Microbiol. Rev. 56, 152-179
52. Webster, R. G., and Govorkova, E. A. (2006). H5N1 influenza-continuing evolution and spread. N. Engl. J. Med. 355, 2174-2177. doi:10.1056/NEJMp068205
53. Whitehead, M., Ohlschlager, P., Almajhdi, F. N., Alloza, L., Marzabal, P., Meyers, A. E., et al. (2014). Human papillomavirus (HPV) type 16 E7 protein bodies cause tumour regression in mice. BMC Cancer 14:367. doi:10.1186/1471-2407-14-367